Coronary physiology before and after chronic total occlusion treatment: what does it tell us?

D C J Keulards1, P J Vlaar2, I Wijnbergen2

  • 1Catharina Hospital, Eindhoven, The Netherlands. Danielle.keulards@catharinaziekenhuis.nl.

Insights

Successful percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) leads to gradual physiological improvements over time. Follow-up assessments guide further treatment, optimizing outcomes and preventing overtreatment.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Chronic total occlusions (CTOs) present a significant challenge in coronary artery disease management.
  • Percutaneous coronary intervention (PCI) aims to restore blood flow but immediate physiological normalization is not typical.

Purpose of the Study:

  • To investigate the temporal physiological changes in CTO vessels and dependent microvasculature after successful PCI.
  • To evaluate the role of follow-up assessments in guiding subsequent interventional decisions.

Main Methods:

  • Analysis of physiological parameters including fractional flow reserve (FFR) in CTO and donor arteries.
  • Assessment of collateral blood supply and microvascular resistance.
  • Utilisation of intravascular imaging for distal vessel analysis.
  • Coronary angiography and physiological measurements at follow-up (weeks to months).

Main Results:

  • Physiological parameters of the CTO vessel and microvasculature improve significantly over time post-PCI.
  • Observed changes include increased FFR in the CTO artery, decreased collateral supply, and improved myocardial perfusion.
  • Positive arterial remodeling of the distal CTO segment occurs over time.

Conclusions:

  • Physiological improvements after CTO PCI are gradual, not immediate.
  • Follow-up physiological assessments are crucial for guiding decisions on residual stenosis treatment and stent optimization.
  • Physiological guidance minimizes overtreatment during the initial procedure and refines understanding of PCI in CTO.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
261
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
163
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
277
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
123
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
142
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
514